What protein binds bilirubin inside the hepatocyte?
Hemopexin binds to which of the following?
In a case of lead poisoning, which of the following levels is elevated?
Which of the following is a hemoprotein?
Which enzyme system continuously reduces the ferric form of iron in the blood to the ferrous form?
What is true about O2 binding to myoglobin?
Which one of the following is a metalloporphyrin?
The pathogenesis of hypochromic anemia in lead poisoning is due to which of the following mechanisms?
What is the composition of a normal adult hemoglobin molecule?
All of the following statements about bilirubin are true EXCEPT:
Explanation: **Explanation:** The correct answer is **Ligandin**. **1. Why Ligandin is correct:** Once unconjugated bilirubin (UCB) reaches the liver, it is dissociated from albumin at the sinusoidal surface of the hepatocyte. It enters the hepatocyte via facilitated diffusion. Inside the cytoplasm, bilirubin must be transported to the endoplasmic reticulum for conjugation. **Ligandin** (also known as **Y-protein** or Glutathione S-transferase B) binds to the bilirubin to prevent its efflux back into the plasma and to keep it solubilized within the aqueous environment of the cell. Another protein, Z-protein, also plays a minor role in this process. **2. Why other options are incorrect:** * **Albumin:** While albumin is the primary carrier of unconjugated bilirubin in the **bloodstream**, it does not enter the hepatocyte with the bilirubin. It stays in the circulation. * **Ubiquinone:** Also known as Coenzyme Q10, this is a component of the electron transport chain in the mitochondria and has no role in bilirubin transport. * **Globulin:** These are a group of proteins in the blood (like immunoglobulins or transport globulins like TBG), but they do not specifically bind bilirubin inside the liver cell. **3. High-Yield Clinical Pearls for NEET-PG:** * **Rate-limiting step:** The excretion of conjugated bilirubin into the bile canaliculi (via MRP2) is the rate-limiting step of bilirubin metabolism, not the binding or conjugation. * **Crigler-Najjar & Gilbert Syndrome:** These involve defects in the enzyme **UDP-glucuronosyltransferase (UGT1A1)**, which conjugates bilirubin *after* it has been bound by ligandin. * **Phenobarbital:** This drug is known to increase the concentration of ligandin in hepatocytes, which helps in the treatment of certain types of hyperbilirubinemia.
Explanation: **Explanation:** **Hemopexin** is a plasma glycoprotein synthesized by the liver that serves as the primary scavenger of **free heme** in the circulation. 1. **Why Option A is Correct:** When red blood cells undergo hemolysis, hemoglobin is released. If this hemoglobin is not bound by haptoglobin, it dissociates into globin chains and heme. Free heme is highly toxic as it promotes oxidative stress and lipid peroxidation. Hemopexin binds to free heme with high affinity, transporting it to the liver. There, the heme-hemopexin complex is internalized via the **CD91 receptor**, allowing for the safe recycling of iron. 2. **Why Other Options are Incorrect:** * **Option B (Hemoglobin):** Hemoglobin is bound by **Haptoglobin**. This complex is too large to be filtered by the kidney, preventing iron loss and renal damage (hemoglobinuria). * **Option C (Iron):** Free ferric iron ($Fe^{3+}$) is transported in the plasma by **Transferrin**, not hemopexin. * **Option D (Bilirubin):** Unconjugated bilirubin is transported to the liver bound to **Albumin**. **High-Yield Clinical Pearls for NEET-PG:** * **Marker of Hemolysis:** In severe or chronic intravascular hemolysis, both Haptoglobin and Hemopexin levels **decrease** because they are consumed faster than the liver can synthesize them. * **Sequence of Depletion:** Haptoglobin is usually depleted first; once its capacity is exceeded, Hemopexin becomes the primary defense against heme toxicity. * **Heme Degradation:** Once inside hepatocytes, heme is broken down by **Heme Oxygenase** into Biliverdin, Carbon Monoxide (CO), and Iron.
Explanation: **Explanation:** Lead poisoning (Plumbism) interferes with heme biosynthesis by inhibiting two key enzymes: **ALA dehydratase** (also known as Porphobilinogen synthase) and **Ferrochelatase**. 1. **Why Delta-aminolevulinic acid (ALA) is elevated:** Lead directly inhibits the enzyme **ALA dehydratase**, which normally converts ALA into porphobilinogen. When this enzyme is blocked, ALA accumulates in the blood and is excreted in excess in the urine (**ALA-uria**). This is a hallmark biochemical finding in lead toxicity. 2. **Why other options are incorrect:** * **Heme:** Lead inhibits Ferrochelatase, the enzyme responsible for inserting iron into Protoporphyrin IX. This results in **decreased** heme synthesis, leading to microcystic hypochromic anemia. * **Bilirubin:** Bilirubin is a degradation product of heme. Since heme synthesis is impaired, there is no primary increase in bilirubin production. * **Motor conduction velocity:** Lead poisoning causes peripheral neuropathy (classically presenting as wrist drop or foot drop). This results in **decreased** motor conduction velocity due to segmental demyelination and axonal degeneration. **High-Yield Clinical Pearls for NEET-PG:** * **Ferrochelatase inhibition:** Leads to an increase in **Erythrocyte Protoporphyrin (EPP)** levels. * **Basophilic Stippling:** Lead inhibits pyrimidine 5'-nucleotidase, causing RNA degradation products to aggregate in RBCs. * **Burton’s Line:** A characteristic bluish-purple line on the gums. * **Radiology:** "Lead lines" (increased metaphyseal density) seen in the long bones of children. * **Treatment:** Chelation therapy with **Succimer** (oral, first-line in children), **Ca-EDTA**, or **British Anti-Lewisite (BAL/Dimercaprol)**.
Explanation: **Explanation:** A **hemoprotein** (or heme protein) is a specialized metalloprotein that contains a heme prosthetic group—a protoporphyrin IX ring coordinated with a central iron atom ($Fe^{2+}$ or $Fe^{3+}$). **Why Cytochrome C is the correct answer:** While all options listed are technically hemoproteins, in the context of standard medical examinations like NEET-PG, this question often tests the identification of specific enzymes or electron carriers within the **Electron Transport Chain (ETC)**. Cytochrome C is a classic example of a hemoprotein where the heme group functions as an electron carrier, cycling between ferrous ($Fe^{2+}$) and ferric ($Fe^{3+}$) states to facilitate ATP production. **Analysis of Options:** * **B, C, and D:** These are also hemoproteins. **Cytochrome P450** is involved in hydroxylation and drug metabolism; **Myoglobin** stores oxygen in muscles; and **Hemoglobin** transports oxygen in the blood. * *Note on Question Structure:* In many competitive exams, if multiple options are correct, the question may be flawed, or it may be seeking the "most representative" example from a specific chapter (e.g., Biological Oxidation). However, strictly biologically, all four are hemoproteins. **High-Yield Clinical Pearls for NEET-PG:** * **Heme Synthesis:** Occurs partly in the mitochondria and partly in the cytosol. The rate-limiting enzyme is **ALA Synthase**. * **Catalase & Peroxidase:** These are also vital hemoproteins that protect against oxidative stress. * **Carbon Monoxide (CO) Poisoning:** CO has a 200x higher affinity for the heme in hemoglobin than oxygen, leading to a leftward shift in the oxygen dissociation curve. * **Cyanide Poisoning:** Cyanide binds to the heme iron ($Fe^{3+}$) in **Cytochrome a3** (Complex IV), halting the ETC.
Explanation: **Explanation:** **1. Why Methemoglobin Reductase is Correct:** In the body, iron in hemoglobin must be in the **ferrous state (Fe²⁺)** to bind oxygen. However, reactive oxygen species spontaneously oxidize iron to the **ferric state (Fe³⁺)**, forming **methemoglobin**, which cannot bind oxygen. To maintain oxygen-carrying capacity, the **NADH-dependent Methemoglobin Reductase system** (also known as Cytochrome b5 reductase) continuously reduces Fe³⁺ back to Fe²⁺. This pathway ensures that methemoglobin levels remain below 1% of total hemoglobin. **2. Why Other Options are Incorrect:** * **Chymotrypsin:** A proteolytic enzyme secreted by the pancreas that aids in protein digestion in the small intestine; it has no role in redox reactions of iron. * **Amylase:** A carbohydrate-digesting enzyme found in saliva and pancreatic juice that hydrolyzes starch into maltose. * **Dehydrogenase:** This is a broad class of enzymes (e.g., Lactate Dehydrogenase) that catalyze oxidation-reduction reactions by transferring hydrogen. While methemoglobin reductase is technically a dehydrogenase, "Methemoglobin reductase" is the specific, clinically relevant system for this process. **3. Clinical Pearls for NEET-PG:** * **Methemoglobinemia:** Occurs when the reduction system is overwhelmed (e.g., exposure to Nitrites, Sulfonamides, or Benzocaine) or congenitally deficient. * **Clinical Presentation:** Patients present with **"Chocolate-colored blood"** and **central cyanosis** that does not improve with supplemental oxygen. * **Treatment:** The drug of choice is **Methylene Blue**, which acts as an electron donor to accelerate the reduction of methemoglobin. * **Shift in Dissociation Curve:** Methemoglobinemia causes a **Left shift** in the Oxygen-Hemoglobin Dissociation Curve, meaning the remaining ferrous heme has an increased affinity for oxygen and does not release it to tissues.
Explanation: **Explanation:** **1. Why Option B is Correct:** Myoglobin (Mb) is a monomeric protein found in muscle tissue that functions primarily as an oxygen storage reservoir. It has a much **higher affinity** for oxygen compared to hemoglobin (Hb). This high affinity allows myoglobin to "pull" oxygen from the blood (hemoglobin) into the muscle cells, even at low partial pressures of oxygen ($PO_2$), ensuring oxygen is available for metabolic processes during muscle contraction. **2. Why Other Options are Incorrect:** * **Option A:** Myoglobin exhibits a **hyperbolic** dissociation curve. The **sigmoid (S-shaped)** curve is characteristic of hemoglobin, representing "cooperative binding" (where the binding of one $O_2$ molecule increases the affinity for subsequent ones). * **Option C:** Myoglobin consists of a single polypeptide chain and one heme group; therefore, it binds only **one molecule of $O_2$**. Hemoglobin, being a tetramer, binds four. * **Option D:** The $P_{50}$ (partial pressure at which 50% of the protein is saturated) for myoglobin is very low, approximately **1–2 mmHg**. A $P_{50}$ of **26 mmHg** is the standard value for adult hemoglobin (HbA). **High-Yield Clinical Pearls for NEET-PG:** * **Left-Shift:** Myoglobin’s curve is far to the left of hemoglobin's, signifying its role in storage rather than transport. * **Bohr Effect:** Myoglobin is **not** affected by allosteric effectors like 2,3-BPG, $CO_2$, or pH (H+ ions), unlike hemoglobin. * **Clinical Marker:** Myoglobin is the **earliest cardiac marker** to rise in Myocardial Infarction (within 1–3 hours), though it lacks specificity compared to Troponins. * **Rhabdomyolysis:** Massive muscle injury releases myoglobin into the blood, which is filtered by the kidneys and can cause acute tubular necrosis (pigment nephropathy).
Explanation: **Explanation:** A **metalloporphyrin** consists of a porphyrin ring (four pyrrole rings linked by methene bridges) coordinated with a central metal ion. **Why Cytochrome is the correct answer:** Cytochromes are heme-containing proteins that function as electron carriers in the electron transport chain (ETC). They contain a **heme group** (Iron + Protoporphyrin IX), making them classic examples of metalloporphyrins. While the question structure is slightly tricky because multiple options contain heme, **Cytochrome** is a quintessential example often tested in the context of the ETC and oxidative phosphorylation. **Analysis of other options:** * **Hemoglobin (B):** Hemoglobin is a **hemoprotein**, consisting of a protein (globin) and a prosthetic group (heme). While heme itself is a metalloporphyrin, "Hemoglobin" refers to the entire conjugated protein complex. In many standardized exams, if both a simple heme-protein and a complex transport protein are listed, the focus is on the functional prosthetic group. * **Bilirubin (C):** This is a **linear tetrapyrrole** (bile pigment). It is the catabolic product of heme degradation. During its formation, the porphyrin ring is cleaved (by heme oxygenase) and the iron is removed; therefore, it is **not** a porphyrin. * **Catalase (D):** Like hemoglobin, catalase is a hemoprotein (containing four heme groups). It is a metalloenzyme, but "Cytochrome" is the more frequent textbook representative for the general category of metalloporphyrins in biochemical classifications. **High-Yield Clinical Pearls for NEET-PG:** * **Common Metalloporphyrins:** Heme (Iron), Chlorophyll (Magnesium), and Vitamin B12 (Cobalt - specifically a *corrin* ring, which is porphyrin-like). * **Heme Synthesis:** The rate-limiting step is catalyzed by **ALA Synthase**, requiring Vitamin B6 (Pyridoxine) as a cofactor. * **Lead Poisoning:** Inhibits **ALA Dehydratase** and **Ferrochelatase**, leading to the accumulation of protoporphyrin.
Explanation: **Explanation:** Lead poisoning (Plumbism) causes hypochromic microcytic anemia primarily by interfering with the **heme biosynthetic pathway**. Lead is a heavy metal that inhibits several enzymes, but two are of critical clinical importance for NEET-PG: 1. **$\delta$-Aminolevulinic Acid Dehydratase (ALAD):** Lead inhibits this enzyme, preventing the conversion of ALA to porphobilinogen. This leads to an accumulation of ALA in the blood and urine. 2. **Ferrochelatase:** This mitochondrial enzyme catalyzes the insertion of ferrous iron ($Fe^{2+}$) into protoporphyrin IX to form heme. Lead inhibits this step, leading to an accumulation of **free erythrocyte protoporphyrin (FEP)**. The resulting deficiency in heme synthesis leads to decreased hemoglobin production, manifesting as hypochromic anemia. **Analysis of Incorrect Options:** * **Option B:** Lead does not significantly compete with iron for transferrin binding; its primary toxicity is enzymatic inhibition rather than transport interference. * **Option C:** While lead can cause shortened red cell survival (hemolysis) by inhibiting pyrimidine 5'-nucleotidase, the primary cause of the *hypochromic* nature of the anemia is the defect in heme synthesis, not membrane binding. * **Option D:** Lead does not interfere with the breakdown of ferritin into hemosiderin. Iron stores (ferritin) are often normal or elevated in lead poisoning because the iron cannot be utilized for heme synthesis. **High-Yield Clinical Pearls for NEET-PG:** * **Basophilic Stippling:** Coarse blue granules in RBCs due to the inhibition of **Pyrimidine 5'-nucleotidase**, leading to the accumulation of ribosomal RNA. * **Burton’s Line:** A bluish-purple line on the gums (gingival lead line). * **Radiology:** "Lead lines" (increased metaphyseal density) seen in the long bones of children. * **Treatment:** Chelation therapy with **Succimer** (oral, first-line in kids), **CaNa₂EDTA**, or **Dimercaprol (BAL)**.
Explanation: **Explanation:** **Normal Adult Hemoglobin (HbA)** is a tetrameric protein responsible for oxygen transport. Its structure is defined by the assembly of four subunits. Each subunit consists of a **globin polypeptide chain** and a **heme prosthetic group**. In a healthy adult, approximately 97% of hemoglobin is HbA, which specifically consists of **two alpha (α) chains and two beta (β) chains**. Since each of the four globin chains must contain one heme group (containing iron in the ferrous $Fe^{2+}$ state) to bind oxygen, the complete molecule contains **four heme molecules**. **Analysis of Options:** * **Option A:** Incorrect. This describes an impossible hybrid. Normal HbA has two pairs of identical chains ($\alpha_2\beta_2$). * **Option B:** Incorrect. While it mentions four heme and four polypeptide chains, it is less specific than Option C, which correctly identifies the specific types of chains ($\alpha$ and $\beta$) required for adult hemoglobin. * **Option D:** Incorrect. This describes a monomeric structure similar to myoglobin, not the tetrameric structure of hemoglobin. **NEET-PG High-Yield Pearls:** * **HbA1 (Adult):** $\alpha_2\beta_2$ (>95%) * **HbA2 (Minor Adult):** $\alpha_2\delta_2$ (1.5–3.5%) * **HbF (Fetal):** $\alpha_2\gamma_2$ (High oxygen affinity; replaced by HbA within 6 months of birth). * **Gower 1:** The earliest embryonic hemoglobin ($\zeta_2\epsilon_2$). * **Cooperativity:** The tetrameric structure allows for "heme-heme interaction," resulting in the characteristic **sigmoidal** oxygen dissociation curve. * **Iron State:** Iron must be in the **Ferrous ($Fe^{2+}$)** state to bind $O_2$. Ferric ($Fe^{3+}$) iron results in Methemoglobin, which cannot bind oxygen.
Explanation: ### Explanation **1. Why Option D is the Correct Answer (The False Statement):** In a healthy adult, approximately **80–85% of bilirubin** is derived from the breakdown of **senescent (aged) erythrocytes** by the mononuclear phagocytic system (spleen and liver). Only about **15–20%** of bilirubin comes from "ineffective erythropoiesis" (destruction of immature RBCs in the bone marrow) and the turnover of other heme-containing proteins like cytochromes, myoglobin, and catalase. Therefore, stating that *most* hemoglobin/bilirubin is derived from ineffective erythropoiesis is physiologically incorrect. **2. Analysis of Other Options:** * **Option A (Hydrophobic and toxic):** Unconjugated bilirubin (UCB) is non-polar and lipid-soluble. Its hydrophobicity allows it to cross the blood-brain barrier, leading to neurotoxicity (Kernicterus), especially in neonates. * **Option B (Tetrapyrrole):** Bilirubin is chemically a linear tetrapyrrole. It is produced by the reduction of biliverdin (also a tetrapyrrole) via the enzyme biliverdin reductase. * **Option C (Daily production):** The normal daily production of bilirubin in an adult is approximately **250–350 mg**, which translates to roughly **4 mg/kg body weight**. **3. High-Yield Clinical Pearls for NEET-PG:** * **Rate-limiting step:** The conversion of heme to biliverdin by **Heme Oxygenase** is the rate-limiting step in bilirubin synthesis. * **Transport:** UCB is transported to the liver bound to **albumin**. It is not excreted in urine (hence, "acholuric" jaundice). * **Conjugation:** Occurs in the ER of hepatocytes via **UDP-glucuronosyltransferase (UGT1A1)**, which adds glucuronic acid to make it water-soluble. * **Van den Bergh Reaction:** UCB gives an **indirect** reaction, while conjugated bilirubin gives a **direct** reaction.
Hemoglobin Structure and Function
Practice Questions
Oxygen Transport and Oxygen-Hemoglobin Dissociation Curve
Practice Questions
Hemoglobin Variants and Hemoglobinopathies
Practice Questions
Thalassemias
Practice Questions
Methemoglobin and Abnormal Hemoglobins
Practice Questions
Hemoglobin Synthesis
Practice Questions
Heme Synthesis and Porphyrias
Practice Questions
Iron Absorption and Transport
Practice Questions
Iron Storage and Recycling
Practice Questions
Disorders of Iron Metabolism
Practice Questions
Anemia: Biochemical Aspects
Practice Questions
Biochemistry of Hemostasis
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free